News VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
0.85 ^USD	+41.67%		+43.07%	+18.55%

Apr. 23	VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	CI
Mar. 26	Transcript : VolitionRx Limited, Q4 2023 Earnings Call, Mar 26, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	Apr. 23	CI
Transcript : VolitionRx Limited, Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
VolitionRx Limited announced that it has received $0.1 million in funding	Mar. 25	CI
VolitionRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
VolitionRx Limited Agrees Supply Agreement with Fujifilm Vet Systems Co. Ltd	Mar. 20	CI
VolitionRx Names Andrew Retter as Chief Medical Officer	Mar. 19	MT
Volitionrx Limited Appoints Andrew Retter as Chief Medical Officer, Effective April 1, 2024	Mar. 19	CI
VolitionRx Limited announced that it expects to receive $0.1 million in funding	Mar. 11	CI
Transcript : VolitionRx Limited - Special Call	Feb. 13
Sector Update: Health Care Stocks Gain Late Afternoon	Jan. 02	MT
Sector Update: Health Care	Jan. 02	MT
VolitionRX Shares Soar After $13.0 Million Milestone Payments From Heska	Jan. 02	MT
VolitionRx Limited Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre	Dec. 05	CI
VolitionRx Limited announced that it has received ?2.5 million in funding	Dec. 04	CI
Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.50 From $2.10, Maintains Overweight Rating	Nov. 16	MT
Transcript : VolitionRx Limited, Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
VolitionRX: Q3 Earnings Snapshot	Nov. 15	AQ
VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Volition and VPG Launch Nu.Q Vet Cancer Test in UK and Ireland	Nov. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News VolitionRx Limited

Equities

VNRX

US9286611077

Summary

Filters